CFDB - Cystic Fibrosis DataBase

at least one term
all terms
All subcategories » trial from other registries

A Phase 3, Open-label, and Rollover Study to Evaluate the Long-term Safety and Tolerability of Lumacaftor/Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation

ongoing trials  trial from other registries

Details
  • 2023

Evaluation of the effects of curcumin-piperine in reducing Pseudomonas infection and improving clinical outcome in patients with cystic fibrosis - Pending

ongoing trials  trial from other registries

Details
  • 2023

The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement

ongoing trials  trial from other registries

Details
  • 2022

Evaluation the effects of camel milk in spirometry parameters in over 6 year’s children with Cystic Fibrosis lung disease - Recruiting

ongoing trials  trial from other registries

Details
  • 2022

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis

ongoing trials  trial from other registries

Details
  • 2021

A Phase 3 Double-blind, Randomized, Placebo-controlled Study Evaluating the Efficacy and Safety of ELX/TEZ/IVA in Cystic Fibrosis Subjects 6 Years of Age and Older With a Non-F508del ELX/TEZ/IVA-responsive CFTR Mutation

ongoing trials  trial from other registries

Details
  • 2021

A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive CFTR Mutation and No F508del Mutation

ongoing trials  trial from other registries

Details
  • 2021

Clinical trial of comparison between use of intravenous aminoglycosides versus intravenous and nebulize aminoglycosides in cystic fibrosis patients - Recruiting

ongoing trials  trial from other registries

Details
  • 2021

Evaluation of the effectiveness of 7% plus hypertonic saline in comparison with 7% hypertonic saline in reducing the growth of Pseudomonas aeruginosa in lung of the patient with cystic fibrosis disease. - Recruiting

ongoing trials  trial from other registries

Details
  • 2021

The effect of compound honey syrup on clinical manifestations of chronic sinusitis in cystic fibrosis (CF) patients - Recruiting

ongoing trials  trial from other registries

Details
  • 2021